Strides Pharma Science gets nod to raise Rs 150 crore via NCDs

Strides Pharma Science

Strides Pharma Science’s board has approved the offering for subscription, on a private placement basis, up to 1,500 senior, secured, rated, unlisted, redeemable, non-convertible debentures (NCDs) of face value Rs 10 lakh each, aggregating up to Rs 150 crore. The board of directors, at its meeting, held on July 25, 2022 has considered and approved … Read more

BREAKING NEWS:
Bajaj’s electric bike: No mileage worries ahead! Hyundai i20 Sales Hit 1.5 Million, Launched 18 Years Ago Affordable Fun: Best 5G Smartphones Under ₹15,000!